David Einhorn’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
David Einhorn's ROIV Position: Q3 2026 in Review
David Einhorn reduced its Roivant Sciences (ROIV) stake by 47% in Q3 2026, selling an estimated $37M and leaving 1,131,747 shares worth $41.4M. The position accounts for 1.16% of the portfolio, ranked #31.
David Einhorn first reported a position in ROIV in Q1 2024 and has held it in 11 quarters since. The position peaked at $76.2M in Q2 2026. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- David Einhorn held 1,131,747 shares of Roivant Sciences worth $41.4M as of Q3 2026.
- David Einhorn sold 1,020,922 Roivant Sciences shares in Q3 2026, an estimated $37M.
- Roivant Sciences made up 1.16% of David Einhorn's portfolio in Q3 2026, its #31 holding.
- David Einhorn first reported a position in Roivant Sciences in Q1 2024 and has held it in 11 quarters since.
- David Einhorn's Roivant Sciences position peaked at $76.2M in Q2 2026.
- 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on DME Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.